Overview

Effect of Rapid Steroid Withdrawal on Subclinical Markers of Rejection

Status:
Terminated
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the safety and efficacy of a tacrolimus-based 5-day steroid rapid withdrawal immunoprophylactic regimen in de novo renal transplantation.
Phase:
Phase 4
Details
Lead Sponsor:
Astellas Pharma Inc
Collaborator:
Astellas Pharma Canada, Inc.
Treatments:
Mycophenolate mofetil
Mycophenolic Acid
Prednisone
Tacrolimus